RxNorm Semantic Concepts Index - 288
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "288".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 2880 | 17,21-hydroxyprogesterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2880 | 17,21-hydroxyprogesterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2880 | 17,21-hydroxyprogesterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2880 | 17,21-hydroxyprogesterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2880 | 17,21-hydroxyprogesterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2880 | 17,21-hydroxyprogesterone | Designated preferred name (PT) | NO | |
RxCUI: 2880 | 17,21-hydroxyprogesterone | Full form of descriptor (FN) | NO | |
RxCUI: 288044 | Aves protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288044 | Aves protein | Full form of descriptor (FN) | NO | |
RxCUI: 288044 | Aves protein | Designated preferred name (PT) | NO | |
RxCUI: 288048 | Glycine max protein (substance) | Full form of descriptor (FN) | NO | |
RxCUI: 288048 | Glycine max protein (substance) | Designated preferred name (PT) | NO | |
RxCUI: 288084 | Tremortin-A | Designated preferred name (PT) | NO | |
RxCUI: 288084 | Tremortin-A | Full form of descriptor (FN) | NO | |
RxCUI: 288084 | Tremortin-A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288088 | Cetrimide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 288088 | Cetrimide | Designated preferred name (PT) | NO | |
RxCUI: 288088 | Cetrimide | Full form of descriptor (FN) | NO | |
RxCUI: 288088 | Cetrimide | Designated preferred name (PT) | NO | |
RxCUI: 288088 | Cetrimide | Full form of descriptor (FN) | NO | |
RxCUI: 288141 | Acarboxy prothrombin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288141 | Acarboxy prothrombin | Designated preferred name (PT) | NO | |
RxCUI: 288141 | Acarboxy prothrombin | Full form of descriptor (FN) | NO | |
RxCUI: 288141 | Acarboxy prothrombin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288141 | Acarboxy prothrombin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 28815 | lithium orotate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 28817 | lithium succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 28817 | lithium succinate | Designated preferred name (PT) | NO | |
RxCUI: 28817 | lithium succinate | Full form of descriptor (FN) | NO | |
RxCUI: 28817 | lithium succinate | Designated preferred name (PT) | NO | |
RxCUI: 28817 | lithium succinate | Full form of descriptor (FN) | NO | |
RxCUI: 28818 | lithium sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 28818 | lithium sulfate | Designated preferred name (PT) | NO | |
RxCUI: 28818 | lithium sulfate | Full form of descriptor (FN) | NO | |
RxCUI: 28818 | lithium sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 288185 | nydrane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 288209 | Temetex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 288239 | Acumentin | Designated preferred name (PT) | NO | |
RxCUI: 288239 | Acumentin | Full form of descriptor (FN) | NO | |
RxCUI: 288250 | ECT - Eosinophil cationic protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288250 | ECT - Eosinophil cationic protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288250 | ECT - Eosinophil cationic protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288250 | ECT - Eosinophil cationic protein | Designated preferred name (PT) | NO | |
RxCUI: 288250 | ECT - Eosinophil cationic protein | Full form of descriptor (FN) | NO | |
RxCUI: 288258 | Span 80 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288262 | cinoxate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 288268 | AP lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288268 | AP lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288268 | AP lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288268 | AP lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288268 | AP lyase | Full form of descriptor (FN) | NO | |
RxCUI: 288268 | AP lyase | Designated preferred name (PT) | NO | |
RxCUI: 288268 | AP lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288295 | D-xylose (nicotinamide adenine dinucleotide phosphate) dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288295 | D-xylose (nicotinamide adenine dinucleotide phosphate) dehydrogenase | Full form of descriptor (FN) | NO | |
RxCUI: 288295 | D-xylose (nicotinamide adenine dinucleotide phosphate) dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 288295 | D-xylose (nicotinamide adenine dinucleotide phosphate) dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288308 | Fabahistin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 288331 | Dicobalt edetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 288331 | Dicobalt edetate | Designated preferred name (PT) | NO | |
RxCUI: 288331 | Dicobalt edetate | Full form of descriptor (FN) | NO | |
RxCUI: 288444 | Calprotectin | Designated preferred name (PT) | NO | |
RxCUI: 288444 | Calprotectin | Full form of descriptor (FN) | NO | |
RxCUI: 28857 | Carob | Designated preferred name (PT) | NO | |
RxCUI: 28857 | Carob | Full form of descriptor (FN) | NO | |
RxCUI: 28859 | Lodoxamide trometamol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 28859 | Lodoxamide trometamol | Full form of descriptor (FN) | YES | |
RxCUI: 28859 | Lodoxamide trometamol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 28859 | Lodoxamide trometamol | Designated preferred name (PT) | YES | |
RxCUI: 28863 | lofexidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 28863 | lofexidine | Designated preferred name (PT) | YES | |
RxCUI: 28863 | lofexidine | Full form of descriptor (FN) | YES | |
RxCUI: 28863 | lofexidine | Designated preferred name (PT) | YES | |
RxCUI: 28863 | lofexidine | Full form of descriptor (FN) | YES | |
RxCUI: 28864 | Loganate methyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 28864 | Loganate methyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 28866 | Festucine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 28866 | Festucine | Designated preferred name (PT) | NO | |
RxCUI: 28866 | Festucine | Full form of descriptor (FN) | NO | |
RxCUI: 28866 | Festucine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288688 | Integrilin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 28872 | lomefloxacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 28872 | lomefloxacin | Designated preferred name (PT) | NO | |
RxCUI: 28872 | lomefloxacin | Full form of descriptor (FN) | NO | |
RxCUI: 28872 | lomefloxacin | Designated preferred name (PT) | NO | |
RxCUI: 28872 | lomefloxacin | Full form of descriptor (FN) | NO | |
RxCUI: 288732 | Evadyne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 28874 | Lomotil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 28876 | lonazolac | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 28880 | Long chain acyl-CoA dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 28880 | Long chain acyl-CoA dehydrogenase | Full form of descriptor (FN) | NO | |
RxCUI: 28880 | Long chain acyl-CoA dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 28880 | Long chain acyl-CoA dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 288862 | flavodic acid, disodium salt | Designated preferred name (PT) | NO | |
RxCUI: 288862 | flavodic acid, disodium salt | Full form of descriptor (FN) | NO | |
RxCUI: 288862 | flavodic acid, disodium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 28889 | Loratadine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 28889 | Loratadine | Designated preferred name (PT) | YES | |
RxCUI: 28889 | Loratadine | Full form of descriptor (FN) | YES | |
RxCUI: 28889 | Loratadine | Designated preferred name (PT) | YES | |
RxCUI: 28889 | Loratadine | Full form of descriptor (FN) | YES | |
RxCUI: 28894 | lormetazepam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 28894 | lormetazepam | Designated preferred name (PT) | NO | |
RxCUI: 28894 | lormetazepam | Full form of descriptor (FN) | NO | |
RxCUI: 28894 | lormetazepam | Designated preferred name (PT) | NO | |
RxCUI: 28894 | lormetazepam | Full form of descriptor (FN) | NO | |
RxCUI: 288999 | cetrimonium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |